Skip to main content
Top
Published in: Abdominal Radiology 8/2015

01-10-2015

Pancreatic neuroendocrine tumors: correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade

Authors: Jose Antonio Sousa Pereira, Elsa Rosado, Maria Bali, Thierry Metens, Shih-Li Chao

Published in: Abdominal Radiology | Issue 8/2015

Login to get access

Abstract

Purpose

To explore the role of histogram analysis of apparent diffusion coefficient (ADC) MRI maps based on entire tumor volume data in determining pancreatic neuroendocrine tumor (PNT) grade.

Methods and Materials

Retrospective evaluation of 22 patients with PNTs included low-grade (G1; n = 15), intermediate-grade (G2; n = 4), and high-grade (G3; n = 3) tumors. Regions of interest containing the lesion were drawn on every section of the ADC map containing the tumor and summated to obtain histograms for entire tumor volume. Calculated histographic parameters included mean ADC (mADC), 5th percentile ADC, 10th percentile ADC, 25th percentile ADC, 50th percentile ADC, 75th percentile ADC (ADC75), 90th percentile ADC (ADC90) and 95th percentile ADC (ADC95), skewness and kurtosis. Histogram parameters were correlated with tumor grade by repeated measures analysis of variance with Tukey–Kramer post hoc comparisons.

Results

The mADC, ADC75, ADC90, and ADC95 were significantly higher in G1 tumors (1283 ± 267; 1404 ± 300; 1495 ± 318; 1562 ± 347 × 10−6 mm2/s) compared to G2 (892 ± 390; 952 ± 381; 1036 ± 384; 1072 ± 374 × 10−6 mm2/s) and to G3 tumors (733 ± 225; 864 ± 284; 1008 ± 288; 1152 ± 192 × 10−6 mm2/s) (p value <0.05). Skewness and kurtosis were significantly different between G1 (0.041 ± 0.466; 2.802 ± 0.679) and G3 (1.01 ± 1.140; 5.963 ± 4.008) tumors (p value <0.05). Tumor volume (mL) was significantly higher on G3 (55 ± 15.7) compared to G1 (1.9 ± 2.7) and G2 (4.5 ± 3.6) tumors (p value <0.05). In this small sample size, we did not detect statistically significant parameters between G2 (n = 4) and G3 (n = 3) tumors.

Conclusions

Histographic analysis of ADC maps on the basis of the entire tumor volume can be useful in differentiating histologic grades of PNTs.
Literature
1.
go back to reference Zhou C, Zhang J, Zheng Y, Zhu Z (2012) Pancreatic neuroendocrine tumors: a comprehensive review. Int J Cancer 131(5):1013–1022CrossRefPubMed Zhou C, Zhang J, Zheng Y, Zhu Z (2012) Pancreatic neuroendocrine tumors: a comprehensive review. Int J Cancer 131(5):1013–1022CrossRefPubMed
2.
go back to reference Fraenkel M, Kim MK, Faggiano A, Valk GD (2012) Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 26(6):691–703CrossRefPubMed Fraenkel M, Kim MK, Faggiano A, Valk GD (2012) Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 26(6):691–703CrossRefPubMed
3.
go back to reference Turaga KK, Kvols LK (2011) Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin 61(2):113–132CrossRefPubMed Turaga KK, Kvols LK (2011) Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin 61(2):113–132CrossRefPubMed
4.
go back to reference Piani C, Franchi GM, Cappelletti C, et al. (2008) Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading. Endocr Relat Cancer 15(1):175–181CrossRefPubMed Piani C, Franchi GM, Cappelletti C, et al. (2008) Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading. Endocr Relat Cancer 15(1):175–181CrossRefPubMed
5.
go back to reference Reid MD, Balci S, Saka B, Adsay NV (2014) Neuroendocrine tumors of the pancreas: current concepts and controversies. Endocr Pathol 25(1):65–79CrossRefPubMed Reid MD, Balci S, Saka B, Adsay NV (2014) Neuroendocrine tumors of the pancreas: current concepts and controversies. Endocr Pathol 25(1):65–79CrossRefPubMed
6.
go back to reference Plockinger U, Rindi G, Arnold R, et al. (2004) Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 80(6):394–424CrossRefPubMed Plockinger U, Rindi G, Arnold R, et al. (2004) Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 80(6):394–424CrossRefPubMed
7.
go back to reference Oberg K, Kvols L, Caplin M, et al. (2004) Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 15(6):966–973CrossRefPubMed Oberg K, Kvols L, Caplin M, et al. (2004) Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 15(6):966–973CrossRefPubMed
8.
go back to reference Pape UF, Jann H, Muller-Nordhorn J, et al. (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113(2):256–265CrossRefPubMed Pape UF, Jann H, Muller-Nordhorn J, et al. (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113(2):256–265CrossRefPubMed
9.
go back to reference Yamaguchi T, Fujimori T, Tomita S, et al. (2013) Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence. Diagn Pathol 8:65PubMedCentralCrossRefPubMed Yamaguchi T, Fujimori T, Tomita S, et al. (2013) Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence. Diagn Pathol 8:65PubMedCentralCrossRefPubMed
10.
go back to reference Ramage JK, Ahmed A, Ardill J, et al. (2012) Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 61(1):6–32PubMedCentralCrossRefPubMed Ramage JK, Ahmed A, Ardill J, et al. (2012) Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 61(1):6–32PubMedCentralCrossRefPubMed
11.
go back to reference Schmid-Tannwald C, Oto A, Reiser MF, Zech CJ (2013) Diffusion-weighted MRI of the abdomen: current value in clinical routine. J Magn Reson Imaging 37(1):35–47CrossRefPubMed Schmid-Tannwald C, Oto A, Reiser MF, Zech CJ (2013) Diffusion-weighted MRI of the abdomen: current value in clinical routine. J Magn Reson Imaging 37(1):35–47CrossRefPubMed
12.
go back to reference Bakir B, Salmaslioglu A, Poyanli A, Rozanes I, Acunas B (2010) Diffusion weighted MR imaging of pancreatic islet cell tumors. Eur J Radiol 74(1):214–220CrossRefPubMed Bakir B, Salmaslioglu A, Poyanli A, Rozanes I, Acunas B (2010) Diffusion weighted MR imaging of pancreatic islet cell tumors. Eur J Radiol 74(1):214–220CrossRefPubMed
13.
go back to reference Wang Y, Chen ZE, Yaghmai V, et al. (2011) Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging 33(5):1071–1079CrossRefPubMed Wang Y, Chen ZE, Yaghmai V, et al. (2011) Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging 33(5):1071–1079CrossRefPubMed
14.
go back to reference Bull JG, Saunders DE, Clark CA (2012) Discrimination of paediatric brain tumours using apparent diffusion coefficient histograms. Eur Radiol 22(2):447–457CrossRefPubMed Bull JG, Saunders DE, Clark CA (2012) Discrimination of paediatric brain tumours using apparent diffusion coefficient histograms. Eur Radiol 22(2):447–457CrossRefPubMed
15.
go back to reference Kang Y, Choi SH, Kim YJ, et al. (2011) Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging—correlation with tumor grade. Radiology 261(3):882–890CrossRefPubMed Kang Y, Choi SH, Kim YJ, et al. (2011) Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging—correlation with tumor grade. Radiology 261(3):882–890CrossRefPubMed
16.
go back to reference Ahn SJ, Choi SH, Kim YJ, et al. (2012) Histogram analysis of apparent diffusion coefficient map of standard and high B-value diffusion MR imaging in head and neck squamous cell carcinoma: a correlation study with histological grade. Acad Radiol 19(10):1233–1240CrossRefPubMed Ahn SJ, Choi SH, Kim YJ, et al. (2012) Histogram analysis of apparent diffusion coefficient map of standard and high B-value diffusion MR imaging in head and neck squamous cell carcinoma: a correlation study with histological grade. Acad Radiol 19(10):1233–1240CrossRefPubMed
17.
go back to reference Hayashida Y, Hirai T, Morishita S, et al. (2006) Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 27(7):1419–1425PubMed Hayashida Y, Hirai T, Morishita S, et al. (2006) Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 27(7):1419–1425PubMed
18.
go back to reference Heo SH, Shin SS, Kim JW, et al. (2013) Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients. Korean J Radiol 14(4):616–625PubMedCentralCrossRefPubMed Heo SH, Shin SS, Kim JW, et al. (2013) Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients. Korean J Radiol 14(4):616–625PubMedCentralCrossRefPubMed
19.
go back to reference Downey K, Riches SF, Morgan VA, et al. (2013) Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images. AJR Am J Roentgenol 200(2):314–320CrossRefPubMed Downey K, Riches SF, Morgan VA, et al. (2013) Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images. AJR Am J Roentgenol 200(2):314–320CrossRefPubMed
20.
go back to reference Brenner R, Metens T, Bali M, Demetter P, Matos C (2012) Pancreatic neuroendocrine tumor: added value of fusion of T2-weighted imaging and high b-value diffusion-weighted imaging for tumor detection. Eur J Radiol 81(5):e746–e749CrossRefPubMed Brenner R, Metens T, Bali M, Demetter P, Matos C (2012) Pancreatic neuroendocrine tumor: added value of fusion of T2-weighted imaging and high b-value diffusion-weighted imaging for tumor detection. Eur J Radiol 81(5):e746–e749CrossRefPubMed
21.
go back to reference Dale BM, Braithwaite AC, Boll DT, Merkle EM (2010) Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen. Invest Radiol 45(2):104–108CrossRefPubMed Dale BM, Braithwaite AC, Boll DT, Merkle EM (2010) Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen. Invest Radiol 45(2):104–108CrossRefPubMed
22.
go back to reference Bender R, Lange S (2001) Adjusting for multiple testing—when and how? J Clin Epidemiol 54(4):343–349CrossRefPubMed Bender R, Lange S (2001) Adjusting for multiple testing—when and how? J Clin Epidemiol 54(4):343–349CrossRefPubMed
23.
go back to reference Kumar R, Indrayan A (2011) Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr 48(4):277–287CrossRefPubMed Kumar R, Indrayan A (2011) Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr 48(4):277–287CrossRefPubMed
Metadata
Title
Pancreatic neuroendocrine tumors: correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade
Authors
Jose Antonio Sousa Pereira
Elsa Rosado
Maria Bali
Thierry Metens
Shih-Li Chao
Publication date
01-10-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 8/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0524-7

Other articles of this Issue 8/2015

Abdominal Radiology 8/2015 Go to the issue

Classics in Abdominal Imaging

The rugger jersey spine

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.